Browse our anti-Apolipoprotein A-I (APOA1) Antibodies

Full name:
anti-Apolipoprotein A-I Antibodies (APOA1)
On are 550 Apolipoprotein A-I (APOA1) Antibodies from 36 different suppliers available. Additionally we are shipping Apolipoprotein A-I Kits (108) and Apolipoprotein A-I Proteins (100) and many more products for this protein. A total of 780 Apolipoprotein A-I products are currently listed.
Alp-1, Apo-AI, apoa, Apoa-1, apoA-I, apoa1, ApoAI, Brp-14, cb49, LOC100136573, Ltw-1, Lvtw-1, MGC64335, MGC89745, Sep-1, Sep-2, Sep2, wu:fb33f01, zgc:103718
list all antibodies Gene Name GeneID UniProt
APOA1 335 P02647
APOA1 11806 Q00623
APOA1 25081 P04639

Show all species

Show all synonyms

All available anti-Apolipoprotein A-I Antibodies

Go to our pre-filtered search.

Top referenced anti-Apolipoprotein A-I Antibodies

  1. Rat (Rattus) Monoclonal APOA1 Primary Antibody for WB - ABIN968824 : Cuthbert, Wang, Zhang, Tam: Regulation of human apolipoprotein A-I gene expression by gramoxone. in The Journal of biological chemistry 1997 (PubMed)
    Show all 2 references for 968824

  2. Human Monoclonal APOA1 Primary Antibody for EIA, RIA - ABIN111352 : Jamil, Gordon, Eustice, Brooks, Dickson, Chen, Ricci, Chu, Harrity, Ciosek, Biller, Gregg, Wetterau: An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. in Proceedings of the National Academy of Sciences of the United States of America 1996 (PubMed)
    Show all 2 references for 111352

  3. Human Monoclonal APOA1 Primary Antibody for EIA, WB - ABIN950461 : Dastani, Dangoisse, Boucher, Desbiens, Krimbou, Dufour, Hegele, Pajukanta, Engert, Genest, Marcil: A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians. in Atherosclerosis 2006 (PubMed)
    Show all 2 references for 950461

  4. Mouse (Murine) Monoclonal APOA1 Primary Antibody for WB - ABIN968823 : Poncin, Martial, Gielen: Cloning and structure analysis of the rat apolipoprotein A-I cDNA. in European journal of biochemistry / FEBS 1984 (PubMed)
    Show all 2 references for 968823

  5. Human Polyclonal APOA1 Primary Antibody for IF (p), IHC (p) - ABIN728968 : Liu, Zhao, Lu, Fan, Wang: Proteomic study on usnic-acid-induced hepatotoxicity in rats. in Journal of agricultural and food chemistry 2012 (PubMed)
    Show all 2 references for 728968

  6. Human Polyclonal APOA1 Primary Antibody for EIA, IHC (fro) - ABIN116540 : Bernthaler, Epping, Schmitz, Deplazes, Brehm: Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode. in Infection and immunity 2009 (PubMed)

  7. Human Polyclonal APOA1 Primary Antibody for EIA, IHC (p) - ABIN359573 : Simó, Higuera, García-Ramírez, Canals, García-Arumí, Hernández: Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. in Archives of ophthalmology 2008 (PubMed)

More Antibodies against Apolipoprotein A-I Interaction Partners

Human Apolipoprotein A-I (APOA1) interaction partners

  1. Findings suggest that the ABCG1 (show ABCG1 Antibodies)-mediated efflux of cholesterol, but not of 7-ketocholesterol, shows specificity for structural domains of apoA-I bound to reconstituted HDL (show HSD11B1 Antibodies). Although the mid region alone of apoA-I associated to rHDL can promote ABCG1 (show ABCG1 Antibodies)-mediated cholesterol efflux, deletion of carboxyl-terminal region 185-243 from full-length apoA-I diminishes ABCG1 (show ABCG1 Antibodies)-mediated cholesterol efflux.

  2. Low APOA1 expression is associated with coronary artery disease severity.

  3. Data suggest that activation of SR-BI (show SCARB1 Antibodies) by APOAI down-regulates sphingosine 1-phosphate/S1PR2 (show S1PR2 Antibodies)-mediated inflammation in vascular endothelial cells by activating the PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) signaling pathway; oxidized-LDL does the opposite. (APOA1 = apolipoprotein A-I; SR-BI/SCARB1 (show SCARB1 Antibodies) = scavenger receptor class B type I; S1PR2 (show S1PR2 Antibodies) = sphingosine 1-phosphate receptor 2 (show S1PR2 Antibodies); PI3K (show PIK3CA Antibodies) = phosphatidylinositol 3-kinase; Akt (show AKT1 Antibodies) = proto-oncogene c-akt (show AKT1 Antibodies))

  4. The minor alleles of rs662799 (APOA5 (show APOA5 Antibodies)) and rs5072 (APOA1) modulate TG levels in Mexican children

  5. Objective of this study was to understand their structural and functional role by generating domain swapped chimeras: apoE3-N-terminal/apoAI-C-terminal and apoAI-N-terminal/apoE (show APOE Antibodies)-C-terminal. Results indicate that the functional attributes of apoAI and apoE3 can be conferred on each other and that N-terminal-C-terminal domain interactions significantly modulate their structure and function.

  6. These data demonstrate that complex of PPARgamma (show PPARG Antibodies) with GW1929 is a negative regulator involved in the control of ApoA-I expression and secretion in human hepatocyte- and enterocyte-like cells

  7. Human apoA-I was overexpressed by transfection in BEL (show LHX2 Antibodies)-7402 hepatocytes and by an adenoviral vector in C57BL/6J mice fed a methionine choline-deficient diet. The overexpression of apoA-I in both models resulted in decreased reactive oxygen species and lipid peroxidation levels, as well as a reduced MAPK (show MAPK1 Antibodies) phosphorylation and decreased expression levels of c-Fos and COX-2 (show COX2 Antibodies).

  8. The H10B sequence repeat of lipid-free human apoA-I is vital in HDL (show HSD11B1 Antibodies) formation.

  9. Our results assign a novel role for 4F(apoA-I mimetic peptide ) as a modulator of the TICE pathway and suggest that the anti-inflammatory functions of 4F may be a partial consequence of the codependent intestinal transport of both 4F and cholesterol.

  10. these data highlight a key role of the P2Y1 (show P2RY1 Antibodies)/PI3Kbeta axis in endothelial cell proliferation downstream of ecto (show TRIM33 Antibodies)-F1-ATPase (show DNAH8 Antibodies) activation by apoA-I. Pharmacological targeting of this pathway could represent a promising approach to enhance vascular endothelial protection.

Mouse (Murine) Apolipoprotein A-I (APOA1) interaction partners

  1. apoA-I/ABCA1 (show ABCA1 Antibodies)-mediated cholesterol efflux without STAT3 (show STAT3 Antibodies) activation can reduce proinflammatory cytokine expression in macrophages.

  2. a novel protective role for ApoA-I in colitis and CAC (show SLC25A20 Antibodies)

  3. Our results assign a novel role for 4F(apoA-I mimetic peptide ) as a modulator of the TICE pathway and suggest that the anti-inflammatory functions of 4F may be a partial consequence of the codependent intestinal transport of both 4F and cholesterol.

  4. Preincubation of endothelial cells with apoA-I protected against the TNF-alpha (show TNF Antibodies)-induced inhibition of HTR (show F2R Antibodies)-8/SVneo (trophoblast) cell integration into endothelial (UtMVEC) networks. These data suggest that a healthy lipid profile may affect pregnancy outcomes by priming endothelial cells in preparation for trophoblast invasion.

  5. Reductions in Dio1 (show DIO1 Antibodies) expression reduce the expression of ApoA-I in a 3,5,3'-triiodothyronine-/thyroid hormone (show PTH Antibodies) response element-independent manner.

  6. apoA-1 deficiency generates changes in the bone cell precursor population that increase adipoblast, and decrease osteoblast production resulting in reduced bone mass and impaired bone quality

  7. This study suggests that enhancement of macrophage cholesterol metabolism by PPARgammais not contributed by activating ABCA1 (show ABCA1 Antibodies) expression and ABCA1 (show ABCA1 Antibodies)-mediated cholesterol efflux to apoAI, which is not involved by CD36 (show CD36 Antibodies) expression either.

  8. Mass spectrometry analysis of peptides derived from chemically crosslinked HDL (show HSD11B1 Antibodies)-SAA (show SAA1 Antibodies) particles detected multiple crosslinks between apoA1 and SAA (show SAA1 Antibodies), indicating close proximity (within 25 A) of these two proteins on the HDL (show HSD11B1 Antibodies) surface, providing a molecular and structural mechanism for the simultaneous binding of heparin to apoA1 and SAA (show SAA1 Antibodies).

  9. results demonstrate that double deletion of Apoe (show APOE Antibodies) and Apoa1 ameliorated the amyloid pathology.

  10. study suggests that apolipoprotein a1 can alleviate obesity related metabolic disease by inducing AMPK (show PRKAA1 Antibodies) dependent mitochondrial biogenesis.

Pig (Porcine) Apolipoprotein A-I (APOA1) interaction partners

  1. Alterations in the Apo A (show APOA Antibodies)-I pattern is a good indicator of the presence and severity of infectious diseases in the pig.Lower overall amounts of Apo A (show APOA Antibodies)-I were observed in Salmonella typhimurium and Escherichia coli infections.

  2. down-regulation of apolipoprotein A-I and A-IV messages in the liver may be mediated by interleukin 6 (show IL6 Antibodies) and tumor necrosis factor-alpha (show TNF Antibodies)

Rabbit Apolipoprotein A-I (APOA1) interaction partners

  1. This study showed that apoA-I exerted protective effects against fatty liver disease in rabbits induced by a high-fat diet, possibly through its antioxidant actions.

  2. The molar ratio ApoE (show APOE Antibodies)/ApoA-I is negatively correlated with the enzyme activity, and positively correlated with increases in the intima-media thickness of common carotid wall and cardiac dysfunction signs.

Cow (Bovine) Apolipoprotein A-I (APOA1) interaction partners

  1. Binding of apoA-I to ectopic F(0)F(1) ATPase (show ATP5E Antibodies) triggers the generation of ADP, which via activation of the purinergic receptor P2Y (show P2RY1 Antibodies)(12) stimulates the uptake and transport of HDL (show HSD11B1 Antibodies) and initially lipid-free apoA-I by endothelial cells.

  2. the model of a two-step process for the transendothelial transport of apoA-I in which apoA-I is initially lipidated by ABCA1 (show ABCA1 Antibodies) and then further processed by ABCA1 (show ABCA1 Antibodies)-independent mechanisms.

Zebrafish Apolipoprotein A-I (APOA1) interaction partners

  1. insulin (show INS Antibodies) secretion and tissue rejuvenation activities of WT-reconstituted high-density lipoproteins were nearly depleted by fructosylation, but V156K-rHDL did not lose its beneficial activity.

  2. The NABB system using engineered zebrafish apo A-I is a native-like membrane mimetic system for G-protein-coupled receptors.

Apolipoprotein A-I (APOA1) Antigen Profile

Antigen Summary

This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis.

Alternative names and synonyms associated with Apolipoprotein A-I (APOA1)

  • apolipoprotein A-I (APOA1) antibody
  • apolipoprotein A-I-like (LOC100386212) antibody
  • apolipoprotein A-I (apoa1) antibody
  • apolipoprotein A-I (apoa-i) antibody
  • apolipoprotein A-I (LOC100136573) antibody
  • apolipoprotein A-I (Apoa1) antibody
  • apolipoprotein A-I (APOAI) antibody
  • apolipoprotein A-Ia (apoa1a) antibody
  • Alp-1 antibody
  • Apo-AI antibody
  • apoa antibody
  • Apoa-1 antibody
  • apoA-I antibody
  • apoa1 antibody
  • ApoAI antibody
  • Brp-14 antibody
  • cb49 antibody
  • LOC100136573 antibody
  • Ltw-1 antibody
  • Lvtw-1 antibody
  • MGC64335 antibody
  • MGC89745 antibody
  • Sep-1 antibody
  • Sep-2 antibody
  • Sep2 antibody
  • wu:fb33f01 antibody
  • zgc:103718 antibody

Protein level used designations for APOA1

apolipoprotein A-I , apolipoprotein A-I-like , apolipoprotein A-I preproprotein , apo-AI , apoA-I , apolipoprotein A1 , apolipoprotein A-1 , preproapolipoprotein A-I , Apolipoprotein A1 , Apolipoprotein A-I , etID309895.5 , etID32161.5

425629 Gallus gallus
696969 Macaca mulatta
100386212 Callithrix jacchus
100528199 Ictalurus punctatus
379421 Xenopus laevis
448709 Xenopus (Silurana) tropicalis
778012 Takifugu rubripes
100126737 Papio anubis
100136573 Salmo salar
335 Homo sapiens
11806 Mus musculus
397691 Sus scrofa
100009253 Oryctolagus cuniculus
25081 Rattus norvegicus
396536 Gallus gallus
281631 Bos taurus
479427 Canis lupus familiaris
443373 Ovis aries
281632 Bos taurus
100454832 Pongo abelii
451564 Pan troglodytes
100196111 Salmo salar
101841336 Mesocricetus auratus
30355 Danio rerio
Selected quality suppliers for anti-Apolipoprotein A-I (APOA1) Antibodies
Did you look for something else?